In this episode, Jagruti shares her experience as an investor from a global perspective and shares her advice to avoid some pitfalls in angel investing. Tune in to the podcast for more

 In swing pricing, the NAV of the fund will be adjusted so that the transaction cost is effectively passed on to the investor whose entry or exit disturbs the NAV. Smaller investors will benefit 

Is there a practical way to decide portfolio level asset allocation which is the most efficient for the kind of risk you as an investor is willing to take? What should be the weightage of each scheme? Here is a practical, scientific and Nobel prize-winning…

The Paytm listing episode raises questions about the ability of fintech companies to match up to the soaring investor expectations

The reason silver is attractive and needs to be considered is that it has the best of both asset classes—gold as well as equities

"Since mid-November, value stocks have outperformed growth stocks by 16.1%"

We sit down with our most popular smallcase managers to discuss this

In today's edition of Moneycontrol Pro Panorama: How oil will behave, the chip pain, Chart of the Day, UP poll fireworks, and more

The fund will be used to invest in early-stage tech startups across FinTech, EdTech, HealthTech, Consumer Internet and Global SaaS, besides EVs, gaming and cryptocurrencies.

Kela has raised his stake in the company to 12.15 percent from 0.06 percent.

AMFI data shows that sector and theme funds added close to 50 lakh new investor accounts over the last two years, highest among active equity oriented funds

The Russia-Ukraine crisis has hammered prices of several global stocks, but most international funds are not accepting fresh investor flows due to overseas investing limits

Risk-taking investors follow extreme strategies of shifting asset classes, entirely. For an Indian investor, exposure to gold makes a lot of sense when there is an expectation of sticky inflation and a weak rupee. But don’t just jump in to buy gold.

The market capitalisation of BSE-listed companies on March 16 stood at Rs 2,54,45,122.12 crore.

Both Orbimed and CDC Group have an extensive healthcare portfolio in India. They invested in AIMS in 2014 and 2018, respectively.